Lack of innovation undermines antibiotic performance and health gains, says WHO

The Edge Markets LogoThe Edge Markets1 mo ago

Lack of innovation undermines antibiotic performance and health gains, says WHO

Quick Summary AI Powered

In the preclinical stage — before clinical trials can start — the number of products has remained relatively constant over the last three years.

On average, resistance is reported to most new agents two to three years post market entry, it said.

Since 2017, only 12 antibiotics have been approved, 10 of which belong to existing classes with established mechanisms of antimicrobial resistance (AMR).

More Pictures


Article Details

Category: InvestingFinance

Topics: Market Development Antibacterial Resistance Three Agents Average Clinical Preclinical Years Antibiotics

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2022-06-24, 02:50:30

News Timezone: GMT +8:00

News Source URL:

Language: English

Reading Time: 3 minutes read

Article Length: 438 words

Coverage Area: Malaysia

Availability: Desktop Web, Mobile Web

News ID: 6961

View Article Analysis

About The Edge Markets

The Edge Markets Logo

Main Topics: InvestingFinance

Official Website:

Update Frequency: 109 posts per day

Year Established: 1994

Headquarters: Malaysia

News Last Updated: 8h ago

Coverage Areas: Malaysia

Ownership: Independent Company

Publication Timezone: GMT +8:00

News Language: English

RSS Feed: Available (XML)

Website Security: Secure (HTTPS)

Publisher ID: #17

Publisher Details

BEAMSTART brings you the latest news, jobs, and events from all around the world on startups, technology, and business. Stay updated with industry news, plug-in to exciting events, and discover incredible career opportunities with the world's most innovative companies.

© Copyright 2022 BEAMSTART. All Rights Reserved.